ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,415Medicare Part D Prescriptions Filled, Including Refills

Rank: 100 out of 1111

$765K Total Retail Price of All Prescriptions

Rank: 83 out of 1111

463 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 463 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

21% of this provider’s 463 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 10,613 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 428 342 S3 1 1
GABAPENTIN 393 338 2 10
LISINOPRIL 384 332 3 2
LEVOTHYROXINE SODIUM 354 349 4 3
SIMVASTATIN 341 304 5 5
OMEPRAZOLE 326 263 6 4
FUROSEMIDE 266 236 7 6
AMLODIPINE BESYLATE 249 219 8 7
TRAMADOL HCL 229 187 9 13
POTASSIUM CHLORIDE 216 197 10 9
METFORMIN HCL 204 173 11 8
METOPROLOL TARTRATE 194 160 12 12
CARVEDILOL 182 163 13 21
ZOLPIDEM TARTRATE 170 141 14 16
CITALOPRAM HBR 160 151 15 14
FAMOTIDINE 155 128 16 77
HYDROCHLOROTHIAZIDE 150 128 17 11
NEXIUM 143 141 18 26
ISOSORBIDE MONONITRATE ER 139 139 19 73
MELOXICAM 130 119 20 18
GLIMEPIRIDE 129 106 21 61
LOVASTATIN 125 111 22 41
POLYETHYLENE GLYCOL 3350 118 117 23 45
DONEPEZIL HCL 115 115 24 25
PANTOPRAZOLE SODIUM 114 98 25 50
ATORVASTATIN CALCIUM 109 90 26 15
CYMBALTA 108 89 27 40
WARFARIN SODIUM 108 89 27 19
NAMENDA 107 95 29 31
FLUTICASONE PROPIONATE 107 84 29 27
ATENOLOL 105 104 31 22
TAMSULOSIN HCL 94 90 32 28
CIPROFLOXACIN HCL 93 85 33 58
METOPROLOL SUCCINATE 93 78 33 20
ROPINIROLE HCL 92 62 35 68
LANTUS 91 32 36 46
CLOPIDOGREL 89 74 37 30
TRAZODONE HCL 87 58 38 32
SOTALOL 87 78 38 294
AZITHROMYCIN 84 76 40 39
DIGOXIN 84 83 40 47
ENALAPRIL MALEATE 83 78 42 56
PAROXETINE HCL 82 66 43 55
ALLOPURINOL 81 75 44 36
RANITIDINE HCL 80 45 45 29
ADVAIR DISKUS 79 78 46 43
FENTANYL 76 65 S2 47 65
FENOFIBRATE 76 60 47 95
TERAZOSIN HCL 75 72 49 127
JANUVIA 74 74 50 75
PLAVIX 70 62 51 49
PREDNISONE 69 60 52 48
FLUOXETINE HCL 69 50 52 44
ALENDRONATE SODIUM 65 59 54 35
TRIAMCINOLONE ACETONIDE 65 64 54 128
SERTRALINE HCL 65 60 54 24
OXYBUTYNIN CHLORIDE ER 65 47 54 114
FINASTERIDE 65 53 54 115
CRESTOR 60 53 59 33
BUSPIRONE HCL 59 59 60 96
PRAVASTATIN SODIUM 57 50 61 17
KLOR-CON M20 55 39 62 79
PROAIR HFA 55 36 62 38
ZETIA 53 53 64 109
SULFAMETHOXAZOLE-TRIMETHOPRIM 53 45 64 71
NOVOLOG 52 28 66 104
ESTRADIOL 50 44 R 67 102
OXYBUTYNIN CHLORIDE 50 32 67 110
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 16, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.